Skip to content

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06169033
Enrollment
800
Registered
2023-12-13
Start date
2024-01-01
Completion date
2027-12-31
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery, Obesity, Type 2 Diabetes Mellitus

Keywords

Obesity, Type 2 Diabetes Mellitus, Radiomics, Abdominal adipose, Subcutaneous adipose, Prediction model

Brief summary

Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.

Detailed description

In this study, the investigator intend to collect abdominal CT from patients who are proposed to undergo bariatric surgery, to extract the radiomics of intra-abdominal fat and subcutaneous fat, and to establish a prediction model for predicting the efficacy of weight loss and remission of type 2 diabetes mellitus at 1 year, 3 years, and 5 years postoperatively, in conjunction with the clinical data.

Interventions

None listed

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 70 Years

Inclusion criteria

* BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery

Exclusion criteria

* Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.

Design outcomes

Primary

MeasureTime frameDescription
Area under curve (AUC) of the weight loss prediction model after 1 year1 yearThis metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 1 year.
Area under curve (AUC) of the T2DM remission prediction model after 1 year1 yearThis metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 1 year.

Secondary

MeasureTime frameDescription
Area under curve (AUC) of the weight loss prediction model after 5 years5 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 5 years.
Area under curve (AUC) of the T2DM remission prediction model after 5 years5 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 5 years.
Area under curve (AUC) of the weight loss prediction model after 3 years3 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 3 years.
Area under curve (AUC) of the T2DM relapse model5 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of T2DM relapse.
Area under curve (AUC) of the weight regain model5 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of weight regain.
Area under curve (AUC) of the T2DM remission prediction model after 3 years3 yearsThis metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 3 years.

Countries

China

Contacts

Primary ContactYuntao Nie, M.D.
nytnyt1231@163.com+8618611835860
Backup ContactHua Meng, M.D.
menghuade@hotmail.com+8618611457779

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026